Literature DB >> 6225669

The absence of systemic side-effects from high doses of ipratropium in the nose.

S Groth, H Dirksen, N Mygind.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6225669

Source DB:  PubMed          Journal:  Eur J Respir Dis Suppl        ISSN： 0106-4347


× No keyword cloud information.
  2 in total

1.  Ipratropium bromide delivered orally by metered dose inhaler does not decrease salivary flow in normal subjects.

Authors:  V E Thomas; F O'Connell; A J Harrison; R W Fuller
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

2.  Ipratropium bromide treatment of experimental rhinovirus infection.

Authors:  M J Gaffey; F G Hayden; J C Boyd; J M Gwaltney
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.